Novo Nordisk to launch lower-cost Ozempic copy in South Africa

Danish pharmaceutical company Novo Nordisk will launch a lower-cost copy of Ozempic in South Africa. This was reported by Qazaqyia.kz citing Reuters.

Ozempic is a popular diabetes drug, often expensive in many countries. This move by Novo Nordisk aims to provide affordable treatment to patients in South Africa.